A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer

Published:2007-10 Issue:9 Volume:18 Page:1103-1107
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Xiong Jian Ping,Zhang Ling,Zhong Lu Xing,Qiu Feng,Xu Jun,Tao Qing Song,Xiang Xiao Jun,Yu Feng,Tang Xiao Mei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference21 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group;Glimelius;Cancer,1994

3. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer;J Clin Oncol,1998

4. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study;De Gramont;J Clin Oncol,1997

5. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers;Raymond;Anticancer Drugs,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma;Anti-Cancer Drugs;2012-06

2. Yiqi Zhuyu Decoction (益气逐瘀汤) Combined with FOLFOX-4 as first-line therapy in metastatic colorectal cancer;Chinese Journal of Integrative Medicine;2011-08

3. A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer;Anti-Cancer Drugs;2009-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3